Primary cutaneous anaplastic large-cell lymphoma with marked spontaneous regression of organ manifestation after SARS-CoV-2 vaccination
Br J Dermatol
.
2021 Dec;185(6):1259-1262.
doi: 10.1111/bjd.20630.
Epub 2021 Oct 3.
Authors
T Gambichler
1
,
S Boms
2
,
S Hessam
2
,
I Tischoff
3
,
A Tannapfel
3
,
T Lüttringhaus
4
,
J Beckman
5
,
R Stranzenbach
1
Affiliations
1
Skin Cancer Center, Department of Dermatology, Ruhr-University Bochum, Bochum, Germany.
2
Department of Dermatology, Christian Hospital Unna, Unna, Germany.
3
Institute of Pathology, Ruhr-University Bochum, Bochum, Germany.
4
Haemato-Oncological Outpatient Clinic, Christian Hospital Unna, Unna, Germany.
5
Department of Radiology, Christian Hospital Unna, Unna, Germany.
PMID:
34228815
PMCID:
PMC8444914
DOI:
10.1111/bjd.20630
No abstract available
Publication types
Letter
MeSH terms
COVID-19 Vaccines
COVID-19*
Humans
Lymphoma, Large-Cell, Anaplastic* / etiology
SARS-CoV-2
Skin Neoplasms*
Vaccination
Substances
COVID-19 Vaccines